Sunday, April 25, 2021 8:19:31 AM
Apr. 07, 2021 3:40 PM ETOncology Pharma Inc. (ONPH)By: Aakash Babu, SA News Editor
Oncology Pharma (OTCPK:ONPH +10.0%) has signed a license agreement with Regen BioPharma for intellectual property pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer.
The license agreement expands the company's portfolio of intellectual property that it plans to develop for niche biotechnology markets.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM